Scientists probe GARP protein's role in heart attacks and chest pain
NCT ID NCT07384910
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at a protein called GARP and related inflammatory markers in the blood of 600 adults with either acute (sudden) or chronic (long-term) coronary syndrome. Participants will have blood drawn during a routine heart catheterization. The goal is to understand how GARP contributes to inflammation in heart disease, which could lead to better treatments in the future.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cliniques Universitaires Saint-Luc
Brussels, 1200, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Ultrasound 'Memory' imaging may reveal hidden heart ischemia
- Could a heart MRI replace invasive scans for some heart attacks?
- Can a tailored Blood-Thinner combo prevent second heart attacks without causing bleeding?
- A sharper eye on the heart: new blood test aims to spot heart attacks faster
- Marathon runners and heart patients put a new troponin test to the ultimate challenge
- Bedside flu shot for heart patients: a simple strategy to save lives?